[Immune responses in women with pre-eclampsia]

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Hepatology

Background:

• Pre-eclampsia is a pregnancy complication affecting maternal and fetal health.
• Alterations in immune markers and liver function are observed in pre-eclampsia.
• The role of specific immunoglobulins in pre-eclampsia requires further elucidation.

Purpose of the Study:

• To investigate levels of Immunoglobulin A (IgA), M (IgM), and G (IgG), transferrin, and T and B lymphocytes in pregnant women with pre-eclampsia.
• To compare these levels with those in women with normal pregnancies.
• To explore potential correlations between immune marker changes and liver function in pre-eclampsia.

Main Methods:

• Serum levels of IgA, IgM, IgG, and transferrin were measured in 26 pregnant women.
• T and B lymphocyte populations were analyzed.
• Participants included 16 women with pre-eclampsia and 10 healthy controls.
• Gestational age and maternal age were recorded for both groups.

Main Results:

• Significantly increased serum levels of Immunoglobulin A (IgA) were observed in women with pre-eclampsia compared to controls.
• No significant differences were found in Immunoglobulin M (IgM), Immunoglobulin G (IgG), transferrin, or T and B lymphocyte counts between the groups.
• The mean age of women with pre-eclampsia was lower (22-30 years) than the control group (30-37 years).

Conclusions:

• Elevated serum IgA is a potential biomarker in pre-eclampsia.
• Reduced hepatobiliary elimination of IgA due to impaired liver function is a plausible explanation for the observed increase.
• Further research is warranted to confirm the link between liver function impairment and IgA levels in pre-eclampsia.